Number of Shares
167,243.00
Current Holdings Value*
$18.50 Mil
% of Portfolio
1.88%
Total Estimate Gain
$1.20 Mil
% of Total Estimate Gain
5.65%

Eversept Partners, LP's Neurocrine Biosciences Inc Holding Summary

As of 2025-03-31, Eversept Partners, LP held 167,243.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $18.50 Mil. This investment constitutes 1.88% of their stock portfolio, and Eversept Partners, LP now holds 0.17% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.

The initial trade took place in 2025Q1. And since then Eversept Partners, LP has made 1 purchases of NBIX, at an average price of $126.68, for a total of 167,243.00 shares. Based on historical transaction data and NBIX's current price of $133.84, Eversept Partners, LP's estimated gain on his NBIX holdings is $1.20 Mil, reflecting a 5.65% gain to date.

Eversept Partners, LP NBIX ($133.84) Holding Chart

Eversept Partners, LP NBIX ($133.84) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1